Literature DB >> 2828434

Comparison of extent of disease and morphometric and DNA flow cytometric prognostic factors in invasive ductal breast cancer.

A M Uyterlinde1, N W Schipper, J P Baak.   

Abstract

In 65 patients with primary invasive ductal breast carcinoma the relation between classic prognosticators describing the extent of disease (lymph node metastases and tumour size) and newer promising morphometric and DNA flow cytometric prognostic factors was studied. There was no relation between DNA ploidy, lymph node state, and tumour size. Tumours with a mitotic activity index of more than 10 were predominantly DNA aneuploid (61%) compared with those with a mitotic activity index of less than 10 which showed a DNA aneuploid pattern in 27%. The strongest prognosticator, the morphometric prognostic index (a multivariate combination of mitotic activity index, tumour size, and lymph node state) correlated positively with the DNA index in 63% of the cases (p = 0.038). Thus there was a discrepancy between the morphometric and DNA flow cytometric prognostic variables in 37% of the cases. These results indicate that morphometric and flow cytometric analysis may provide additional information on the prognosis in primary breast cancer.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2828434      PMCID: PMC1141279          DOI: 10.1136/jcp.40.12.1432

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  24 in total

1.  DNA content and survival in mammary carcinoma.

Authors:  G U Auer; T O Caspersson; A S Wallgren
Journal:  Anal Quant Cytol       Date:  1980-09

2.  Predicting breast cancer recurrence.

Authors:  B Stenkvist; E Bengtsson; B Dahlqvist; G Eklund; O Eriksson; T Jarkrans; B Nordin
Journal:  Cancer       Date:  1982-12-15       Impact factor: 6.860

3.  The world Health Organization Histological Typing of Breast Tumors--Second Edition. The World Organization.

Authors: 
Journal:  Am J Clin Pathol       Date:  1982-12       Impact factor: 2.493

4.  Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.

Authors:  W A Knight; R B Livingston; E J Gregory; W L McGuire
Journal:  Cancer Res       Date:  1977-12       Impact factor: 12.701

5.  Prognosis in breast cancer utilizing histologic characteristics of the primary tumor.

Authors:  M M Black; T H Barclay; B F Hankey
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

6.  Flow cytometry of breast carcinoma: I. Relation of DNA ploidy level to histology and estrogen receptor.

Authors:  W Olszewski; Z Darzynkiewicz; P P Rosen; M K Schwartz; M R Melamed
Journal:  Cancer       Date:  1981-08-15       Impact factor: 6.860

7.  The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancer.

Authors:  R Hilf; M L Feldstein; S L Gibson; E D Savlov
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

8.  Management and survival of female breast cancer: results of a national survey by the American College of Surgeons.

Authors:  T Nemoto; J Vana; R N Bedwani; H W Baker; F H McGregor; G P Murphy
Journal:  Cancer       Date:  1980-06-15       Impact factor: 6.860

9.  Flow cytometry and cytomorphology in primary resectable breast cancer.

Authors:  C W Bedrossian; M Raber; B Barlogie
Journal:  Anal Quant Cytol       Date:  1981-06

10.  Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1465 cases.

Authors:  N B Atkin; R Kay
Journal:  Br J Cancer       Date:  1979-08       Impact factor: 7.640

View more
  8 in total

1.  Prognostic value of proliferative activity in lymph node metastases of patients with breast cancer.

Authors:  P J van Diest; E Matze-Cok; J P Baak
Journal:  J Clin Pathol       Date:  1991-05       Impact factor: 3.411

2.  Lymph node metastases versus DNA ploidy as prognostic factors for invasive ductal carcinoma of the breast.

Authors:  M Noguchi; T Taniya; N Ohta; N Koyasaki; I Miyazaki; Y Mizukami
Journal:  Breast Cancer Res Treat       Date:  1991-09       Impact factor: 4.872

3.  A retrospective study on the clinical and biological prediction of axillary lymph node metastasis in breast cancer.

Authors:  M Noguchi; N Ohta; M Thomas; H Kitagawa; M Earashi; I Miyazaki; Y Mizukami
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

4.  DNA ploidy and helix pomatia lectin binding as predictors of regional lymph node metastases and prognostic factors in breast cancer.

Authors:  M Noguchi; M Thomas; H Kitagawa; K Kinishita; S Kinami; H Takamura; I Miyazaki; Y Mizukami
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

5.  At convenience and systematic random sampling: effects on the prognostic value of nuclear area assessments in breast cancer patients.

Authors:  I Jannink; J N Bennen; J Blaauw; P J van Diest; J P Baak
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

6.  The relationship between lymph node metastases and DNA-ploidy status as prognostic factors in invasive breast cancer.

Authors:  M Noguchi; N Ohta; N Koyasaki; T Taniya; I Miyazaki; Y Mizukami
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

7.  DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients.

Authors:  C R Wenger; S Beardslee; M A Owens; G Pounds; T Oldaker; P Vendely; M R Pandian; D Harrington; G M Clark; W L McGuire
Journal:  Breast Cancer Res Treat       Date:  1993-10       Impact factor: 4.872

8.  Screen-detected breast cancers have a lower mitotic activity index.

Authors:  R P Groenendijk; P Bult; L Tewarie; P G Peer; R F van der Sluis; T J Ruers; T Wobbes
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.